Cell and Gene Regulatory
-
Esco IntelliGlove Tester (EIGT)
2/19/2026
Ensure sterility with wireless glove leak testing. Align with Annex 1 and ISO standards through portable, traceable, and cable-free integrity checks that optimize cleanroom safety and workflows.
-
0.45 m/s ±20% At Working Position In Closed Sterility Testing Isolators: Requirement Or Convention?
2/19/2026
Balance compliance and efficiency in sterility testing. Explore how a risk-based approach to airflow and isolator technology aligns with Annex 1 while optimizing contamination control.
-
Esco Pharmaceutical Products Catalogue
2/19/2026
Secure your process with advanced isolation and airflow containment. From ISO Class 5 environments to cytotoxic safety, these solutions ensure peak protection and global regulatory compliance.
-
Pharma Product Guide
2/19/2026
Enhance your clinical and pharmaceutical workflows with advanced containment. From ISO Class 5 environments to modular isolation, find scalable solutions to protect integrity and ensure safety.
- Redefining Glove Integrity Testing: Esco IntelliGlove Tester (EIGT) 2/19/2026
-
Cold Chain Compliance Standards You Should Know About
2/18/2026
Regulatory frameworks for biopharmaceutical cold chain management are more interconnected than most manufacturers expect — and the gaps between them are where compliance risk lives.
-
Inside Mesoblast's Playbook For Making Allogeneic Cell Therapy Real
2/18/2026
Mesoblast's Silviu Itescu shares how two decades of rigorous science and manufacturing turned allogeneic MSCs into the first FDA-approved cell therapy while building a scalable platform for inflammatory diseases such as GvHD, back pain, and heart failure.
-
What FDA CRLs Reveal About E&L
2/18/2026
FDA feedback shows E&L gaps still delay approvals. This preview flags common issues — from unknown compounds to weak tox data — and offers ways to strengthen E&L approaches and cut regulatory risk.
-
U.S. Pharma Tariffs And MFN In 2026: Manufacturing And Procurement Impact
2/18/2026
Beroe Inc.'s Mathini Ilancheran discusses the 2025 U.S. pharma tariff framework and translates it into actionable procurement and outsourcing responses.
-
Practical USP <1665>/<665> Guide To E&L Risk Assessment
2/17/2026
A practical USP <1665> and <665> framework helps manufacturers evaluate and manage extractables and leachables risk, supporting quality, safety, and regulatory compliance.